The Global Cognition, Frontal Lobe Dysfunction and Behavior Changes in Chinese Patients with Multiple System Atrophy

Background Studies on cognition in multiple system atrophy (MSA) patients are limited. Methods A total of 110 MSA patients were evaluated using Addenbrooke's Cognitive Examination-Revised (ACE-R), Frontal Assessment Battery (FAB), Frontal Behavioral Inventory (FBI), and Unified MSA Rating Scale (UMSARS) tests. Fifty-five age-, sex-, education- and domicile-matched healthy controls were recruited to perform the FAB and ACE-R scales. Results Approximately 32.7% of the patients had global cognitive deficits with the most impaired domain being verbal fluency and visuospatial ability (26.4%), followed by memory (24.5%), language (20%) and orientation/attention (20%) based on a cut-off score of ACE-R ≤ 70. A total of 41.6% of the patients had frontal lobe dysfunction, with inhibitory control (60.9%) as the most impaired domain based on a cut-off score of FAB ≤14. Most patients (57.2%) showed moderate frontal behavior changes (FBI score 4–15), with incontinence (64.5%) as the most impaired domain. The binary logistic regression model revealed that an education level < 9 years (OR:13.312, 95% CI:2.931–60.469, P = 0.001) and UMSARS ≥ 40 (OR: 2.444, 95%CI: 1.002–5.962, P< 0.049) were potential determinants of abnormal ACE-R, while MSA-C (OR: 4.326, 95%CI: 1.631–11.477, P = 0.003), an education level < 9 years (OR:2.809 95% CI:1.060–7.444, P = 0.038) and UMSARS ≥ 40 (OR:5.396, 95%CI: 2.103–13.846, P < 0.0001) were potential determinants of abnormal FAB. Conclusions Cognitive impairment is common in Chinese MSA patients. MSA-C patients with low education levels and severe motor symptoms are likely to experience frontal lobe dysfunction, while MSA patients with low education levels and severe motor symptoms are likely to experience global cognitive deficits. These findings strongly suggest that cognitive impairment should not be an exclusion criterion for the diagnosis of MSA.

[1]  Rui Huang,et al.  Screening for cognitive impairment in a Chinese ALS population , 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[2]  S. Naismith,et al.  Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease. , 2015, Parkinsonism & related disorders.

[3]  Rui Huang,et al.  Frontal lobe function and behavioral changes in amyotrophic lateral sclerosis: a study from Southwest China , 2014, Journal of Neurology.

[4]  W. Poewe,et al.  Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group , 2014, Movement disorders : official journal of the Movement Disorder Society.

[5]  Abigail L. Person,et al.  Cerebellar Loops: A Review of the Nucleocortical Pathway , 2013, The Cerebellum.

[6]  W. Xu,et al.  Validation of the Chinese Version of Addenbrooke's Cognitive Examination-Revised for Screening Mild Alzheimer's Disease and Mild Cognitive Impairment , 2013, Dementia and Geriatric Cognitive Disorders.

[7]  R. Carpenter,et al.  A Longitudinal Study of Motor, Oculomotor and Cognitive Function in Progressive Supranuclear Palsy , 2013, PloS one.

[8]  R. Barker,et al.  The Addenbrooke’s Cognitive Examination-Revised accurately detects cognitive decline in Huntington’s disease , 2013, Journal of Neurology.

[9]  Young Eun Kim,et al.  Clinical and imaging characteristics of dementia in multiple system atrophy. , 2013, Parkinsonism & related disorders.

[10]  J. Starr,et al.  Does the Addenbrooke's Cognitive Examination‐revised add to the Mini‐Mental State Examination in established Alzheimer disease? Results from a national dementia research register , 2013, International journal of geriatric psychiatry.

[11]  E. Tolosa,et al.  A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type , 2013, Journal of Neural Transmission.

[12]  J. Kállai,et al.  Sensitivity and specificity of Addenbrooke's Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson's disease. , 2012, Parkinsonism & related disorders.

[13]  E. Mori,et al.  A Validation Study of the Japanese Version of the Addenbrooke's Cognitive Examination-Revised , 2012, Dementia and Geriatric Cognitive Disorders Extra.

[14]  C. Adler,et al.  MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI , 2011, Movement disorders : official journal of the Movement Disorder Society.

[15]  G. Halliday,et al.  Utility and Limitations of Addenbrooke’s Cognitive Examination-Revised for Detecting Mild Cognitive Impairment in Parkinson’s Disease , 2011, Dementia and Geriatric Cognitive Disorders.

[16]  C. Jack,et al.  Gray matter correlates of behavioral severity in progressive supranuclear palsy , 2011, Movement disorders : official journal of the Movement Disorder Society.

[17]  T. Shimohata,et al.  Factors influencing the cognitive function in patients with multiple system atrophy , 2010, Movement disorders : official journal of the Movement Disorder Society.

[18]  Elvira Brattico,et al.  Cognitive and Motor Loops of the Human Cerebro-cerebellar System , 2010, Journal of Cognitive Neuroscience.

[19]  Y. Kwak,et al.  Korean Addenbrooke's Cognitive Examination Revised (K‐ACER) for differential diagnosis of Alzheimer's disease and subcortical ischemic vascular dementia , 2010, Geriatrics & gerontology international.

[20]  Y. Agid,et al.  Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. , 2010, Brain : a journal of neurology.

[21]  P. Caramelli,et al.  Brazilian Version of the Addenbrooke Cognitive Examination-revised in the Diagnosis of Mild Alzheimer Disease , 2010, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[22]  G. Wenning,et al.  Multiple system atrophy: an update , 2009, The Lancet Neurology.

[23]  C. Christine,et al.  Cognitive and Neuropsychiatric Profile of the Synucleinopathies: Parkinson Disease, Dementia With Lewy Bodies, and Multiple System Atrophy , 2009, Alzheimer disease and associated disorders.

[24]  Yen-Hsiang Chang,et al.  Cognitive deficits in multiple system atrophy correlate with frontal atrophy and disease duration , 2009, European journal of neurology.

[25]  A. Pisani,et al.  Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study , 2009, Journal of Neurology.

[26]  C. Lima,et al.  The Frontal Assessment Battery (FAB) in Parkinson’s disease and correlations with formal measures of executive functioning , 2008, Journal of Neurology.

[27]  P Sandroni,et al.  Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.

[28]  K. Ito,et al.  Cognitive impairments in multiple system atrophy , 2008, Neurology.

[29]  M. S. Lee,et al.  Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy. , 2008, Brain : a journal of neurology.

[30]  M. Viitanen,et al.  Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease , 2008, Annals of neurology.

[31]  P. Lantos,et al.  A quantitative study of the pathological changes in white matter in multiple system atrophy , 2007, Neuropathology : official journal of the Japanese Society of Neuropathology.

[32]  Michael Schocke,et al.  Progression of brain atrophy in multiple system atrophy , 2007, Journal of Neurology.

[33]  H. Sasaki,et al.  MSA-C is the predominant clinical phenotype of MSA in Japan: Analysis of 142 patients with probable MSA , 2006, Journal of the Neurological Sciences.

[34]  M. T. Pellecchia,et al.  Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA Study Group (EMSA SG) , 2006, Movement disorders : official journal of the Movement Disorder Society.

[35]  H. Braak,et al.  Cognitive status correlates with neuropathologic stage in Parkinson disease , 2005, Neurology.

[36]  T. Rogers,et al.  Cognitive bedside assessment in atypical parkinsonian syndromes , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[37]  Sid Gilman,et al.  Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS) , 2004, Movement disorders : official journal of the Movement Disorder Society.

[38]  Scott A Langenecker,et al.  fMRI of healthy older adults during Stroop interference , 2004, NeuroImage.

[39]  Sarah E. MacPherson,et al.  Age, executive function, and social decision making: a dorsolateral prefrontal theory of cognitive aging. , 2002, Psychology and aging.

[40]  Y. Hashizume,et al.  Multiple system atrophy with remarkable frontal lobe atrophy , 1999, Acta Neuropathologica.

[41]  Hitoshi Takahashi,et al.  Multiple system atrophy with severe involvement of the motor cortical areas and cerebral white matter , 1998, Journal of the Neurological Sciences.

[42]  A. Kertesz,et al.  Frontal Behavioral Inventory: Diagnostic Criteria for Frontal Lobe Dementi , 1997, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[43]  M. Albert,et al.  Level of education and change in cognitive function in a community population of older persons. , 1993, Annals of epidemiology.